losartan and copper sulfate

losartan has been researched along with copper sulfate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Attias, J; Breslow, JL; Hayek, T; Keidar, S; Smith, J	1

Other Studies

1 other study(ies) available for losartan and copper sulfate

Article	Year
The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice. Biochemical and biophysical research communications, 1997, Jul-30, Volume: 236, Issue:3 Topics: Angiotensin Receptor Antagonists; Animals; Apolipoproteins E; Arteriosclerosis; Biphenyl Compounds; Copper Sulfate; Imidazoles; Lipid Peroxidation; Lipoproteins, LDL; Losartan; Malondialdehyde; Mice; Mice, Mutant Strains; Oxidation-Reduction; Oxidative Stress; Renin; Tetrazoles	1997

Article

Year

The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice.

Biochemical and biophysical research communications, 1997, Jul-30, Volume: 236, Issue:3

Topics: Angiotensin Receptor Antagonists; Animals; Apolipoproteins E; Arteriosclerosis; Biphenyl Compounds; Copper Sulfate; Imidazoles; Lipid Peroxidation; Lipoproteins, LDL; Losartan; Malondialdehyde; Mice; Mice, Mutant Strains; Oxidation-Reduction; Oxidative Stress; Renin; Tetrazoles

1997